HealthcareServices

Automation In Biopharma Industry Market Outlook: Growth and Forecast Highlights 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the automation in biopharma industry market from 2026–2035 with trusted insights from The Business Research Company

How much is the Automation In Biopharma Industry Market valued at in 2026, and what valuation is forecast for 2030?

The market size for automation in the biopharma industry has shown robust growth in recent years. It is anticipated to increase from $2.19 billion in 2025 to $2.35 billion in 2026, at a compound annual growth rate (CAGR) of 7.1%. The historical expansion can be attributed to the increasing complexity of biologic drug production, rising demand for scalable biopharma manufacturing, early adoption of laboratory automation, expansion of contract manufacturing services, and advancements in process control technologies.

The automation in biopharma industry market is predicted to experience robust expansion over the coming years. It is projected to achieve a value of $3.16 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.7%. This anticipated growth is driven by factors such as increasing investments in intelligent biomanufacturing facilities, the rising adoption of continuous manufacturing processes, the expansion of personalized biologics production, a surging demand for regulatory-compliant automation solutions, and a heightened emphasis on optimizing manufacturing efficiency. Furthermore, significant trends for this period encompass the increasing embrace of robotic manufacturing platforms, the growing integration of digital twin technologies, an expanding use of automated quality control systems, the broadening of end-to-end bioprocess automation, and a strengthened focus on data-driven manufacturing approaches.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Drivers Are Influencing The Growth Of The Automation In Biopharma Industry Market?

The expanded utilization of robots in pharmaceutical manufacturing is projected to stimulate the growth of the automation in biopharma industry market. These robots are sophisticated automated systems and machines capable of performing various tasks in the production and packaging of pharmaceutical products. They are frequently employed in numerous applications within pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy processes, and personalized medicine, thereby boosting productivity, improving precision, reducing contamination risks, and enhancing worker safety. For example, in September 2024, data from the International Federation of Robotics, a professional non-profit organization based in Germany, showed that industrial robot installations in Europe’s manufacturing industry climbed by 9%, reaching an unprecedented 92,393 units. Of this total, 80% were installed within the European Union, amounting to 73,534 units, representing a 2% increase from the previous year. Thus, the rising adoption of robots in pharmaceutical manufacturing will be a key driver for the growth of the automation in biopharma industry market.

How Is The Automation In Biopharma Industry Market Organized Into Various Segments?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Which Competitive Trends Are Impacting The Structure Of The Automation In Biopharma Industry Market?

Major companies in the biopharma industry market are adopting automation, concentrating on developing technological advancements such as robotic cell-therapy manufacturing platforms to achieve scalable, efficient, and reduced-error production of advanced therapies. A robotic cell-therapy manufacturing platform combines mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control within a fully closed and modular system, thereby replacing traditional manual bioprocessing that relies heavily on labor and open systems. For instance, in May 2023, Cellular Origins, a UK-based life sciences automation company, unveiled Constellation, a configurable robotic platform designed for advanced therapy manufacture. This platform integrates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, allowing for seamless integration with existing bioprocessing workflows. It boosts space efficiency by 30 times, reduces labor requirements by 16-fold, and cuts production costs by 51%, while also offering full digital interconnection for quality control and remote monitoring.

Who Are The Major Companies Operating In The Automation In Biopharma Industry Market?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Automation In Biopharma Industry Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Pharmacy Automation Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Bioprocess Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795